Blue Ridge Capital’s Illumina ILMN Stock Holding History

Blue Ridge Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,043,420	Closed	-$178M	–	50
2015 Q3	$178M	Buy	+1,043,420	New	+$211M	2.05%	23

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Blue Ridge Capital's ILMN Position: Q4 2015 in Review

Blue Ridge Capital sold out of Illumina (ILMN) in Q4 2015, closing a stake of 1,043,420 shares — an estimated $178M sold.

Blue Ridge Capital first reported a position in ILMN in Q3 2015 and held it in 1 quarter. The position peaked at $178M in Q3 2015. 560 funds tracked by Wall St. Rank hold ILMN as of Q4 2015.

Blue Ridge Capital reported no remaining Illumina position as of Q4 2015 after selling out during the quarter.
Blue Ridge Capital sold 1,043,420 Illumina shares in Q4 2015, an estimated $178M.
Blue Ridge Capital first reported a position in Illumina in Q3 2015 and held it in 1 quarter.
Blue Ridge Capital's Illumina position peaked at $178M in Q3 2015.
560 funds tracked by Wall St. Rank held Illumina as of Q4 2015.

Based on Blue Ridge Capital's 13F filing for Q4 2015, filed 16 Feb 2016.